Veterinary Vaccines Market- Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Vaccine Type, By Technology, By Region & Competition, 2020-2030F

Description

The Global Veterinary Vaccines Market was valued at USD 8.44 billion in 2024 and is projected to grow at a CAGR of 7.28% through 2030. This market plays a critical role in veterinary healthcare by providing vaccines designed to prevent and manage diseases in both companion animals and livestock. These vaccines are essential for ensuring animal health, maintaining food security, and reducing the risk of zoonotic disease transmission. Growing demand for ethical and sustainable animal products, coupled with advancements in vaccine technology and the rise of platform-based solutions for emerging diseases, are contributing to market expansion. Innovations like the European Medicines Agency's certification of the Innovax vPTMF, a turkey herpesvirus vector platform, demonstrate the industry's commitment to rapid response and improved vaccine accessibility. As awareness around animal health continues to rise, the veterinary vaccines market is poised for strong growth globally.

Market Overview
Forecast Period	2026-2030
Market Size 2024	USD 8.44 Billion
Market Size 2030	USD 12.76 Billion
CAGR 2025-2030	7.28%
Fastest Growing Segment	Live Attenuated Vaccine
Largest Market	North America

Key Market Drivers

Growing Awareness of Animal Welfare

Increasing public awareness regarding animal welfare is a key factor driving the veterinary vaccines market. Pet owners are more invested in the health of their animals, prioritizing routine vaccinations to extend the life and quality of their pets. Similarly, in livestock farming, the focus on humane treatment and productivity has prompted producers to adopt preventive healthcare strategies, including vaccination. Ethical consumerism is shaping market demand, as buyers prefer products sourced from healthy and well-treated animals. Regulatory frameworks and animal welfare certifications now often include vaccine requirements as part of disease prevention protocols. A notable development is the European Medicines Agency's 2024 certification of the Innovax vPTMF vaccine platform, which enables rapid customization of vaccines to address emerging threats, bolstering preparedness and public health resilience.

Key Market Challenges

Regulatory Hurdles and Approval Processes

The veterinary vaccines market is significantly impacted by the complex and varying regulatory standards across global regions. Navigating country-specific approval processes presents a substantial challenge for manufacturers, often leading to high compliance costs and extended timelines. Regulatory agencies demand rigorous safety and efficacy evaluations, including detailed preclinical and clinical testing. These requirements, while essential for public and animal health, add layers of complexity that slow down time-to-market for new vaccines. Delays in vaccine registration further hinder growth, especially for companies looking to respond swiftly to evolving disease patterns.

Key Market Trends

Increasing Focus on Preventive Healthcare

An emerging trend across the veterinary landscape is the heightened emphasis on preventive care through vaccination. Both pet owners and livestock producers are increasingly aware of the benefits of immunization in minimizing disease outbreaks, reducing treatment costs, and enhancing animal welfare. Preventive healthcare is now viewed as a strategic investment, particularly in the companion animal sector where routine vaccinations are standard. In livestock operations, preventive vaccination supports herd health and productivity, reducing economic losses linked to illness. This trend is reshaping the approach to animal care, prioritizing early intervention and long-term health maintenance.

Key Market Players

Zoetis Inc.
Merck & Co. Inc.
Virbac SA
Hester Biosciences Limited
Elanco Animal Health
Boehringer Ingelheim International GmbH
Ceva Sante Animale
Phibro Animal Health Corporation
HIPRA

Report Scope:

In this report, the Global Veterinary Vaccines Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Veterinary Vaccines Market, By Vaccine Type:

Livestock Vaccine
Companion Animal Vaccine

Veterinary Vaccines Market, By Technology:

Live Attenuated Vaccines
Inactivated Vaccines
Toxoid Vaccines
Recombinant Vaccines
Other

Veterinary Vaccines Market, By Region:

North America
- United States
- Canada
- Mexico
Europe
- France
- United Kingdom
- Italy
- Germany
- Spain
Asia-Pacific
- China
- India
- Japan
- Australia
- South Korea
South America
- Brazil
- Argentina
- Colombia
Middle East & Africa
- South Africa
- Saudi Arabia
- UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Veterinary Vaccines Market.

Available Customizations:

Global Veterinary Vaccines market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

1. Product Overview

1.1. Market Definition
1.2. Scope of the Market
- 1.2.1. Markets Covered
- 1.2.2. Years Considered for Study
- 1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries

4. Overview of Market Drivers, Challenges, Trends

5. Voice of Customer

6. Global Veterinary Vaccines Market Outlook

6.1. Market Size & Forecast
- 6.1.1. By Value
6.2. Market Share & Forecast
- 6.2.1. By Vaccine Type (Livestock Vaccine, Companion Animal Vaccine)
- 6.2.2. By Technology (Live Attenuated Vaccines, Inactivated Vaccines, Toxoid Vaccines, Recombinant Vaccines, Other)
- 6.2.3. By Region
- 6.2.4. By Company (2024)
6.3. Market Map

7. North America Veterinary Vaccines Market Outlook

7.1. Market Size & Forecast
- 7.1.1. By Value
7.2. Market Share & Forecast
- 7.2.1. By Vaccine Type
- 7.2.2. By Technology
- 7.2.3. By Country
7.3. North America: Country Analysis
- 7.3.1. United States Veterinary Vaccines Market Outlook
  - 7.3.1.1. Market Size & Forecast
    - 7.3.1.1.1. By Value
  - 7.3.1.2. Market Share & Forecast
    - 7.3.1.2.1. By Vaccine Type
    - 7.3.1.2.2. By Technology
- 7.3.2. Canada Veterinary Vaccines Market Outlook
  - 7.3.2.1. Market Size & Forecast
    - 7.3.2.1.1. By Value
  - 7.3.2.2. Market Share & Forecast
    - 7.3.2.2.1. By Vaccine Type
    - 7.3.2.2.2. By Technology
- 7.3.3. Mexico Veterinary Vaccines Market Outlook
  - 7.3.3.1. Market Size & Forecast
    - 7.3.3.1.1. By Value
  - 7.3.3.2. Market Share & Forecast
    - 7.3.3.2.1. By Vaccine Type
    - 7.3.3.2.2. By Technology

8. Europe Veterinary Vaccines Market Outlook

8.1. Market Size & Forecast
- 8.1.1. By Value
8.2. Market Share & Forecast
- 8.2.1. By Vaccine Type
- 8.2.2. By Technology
- 8.2.3. By Country
8.3. Europe: Country Analysis
- 8.3.1. Germany Veterinary Vaccines Market Outlook
  - 8.3.1.1. Market Size & Forecast
    - 8.3.1.1.1. By Value
  - 8.3.1.2. Market Share & Forecast
    - 8.3.1.2.1. By Vaccine Type
    - 8.3.1.2.2. By Technology
- 8.3.2. United Kingdom Veterinary Vaccines Market Outlook
  - 8.3.2.1. Market Size & Forecast
    - 8.3.2.1.1. By Value
  - 8.3.2.2. Market Share & Forecast
    - 8.3.2.2.1. By Vaccine Type
    - 8.3.2.2.2. By Technology
- 8.3.3. Italy Veterinary Vaccines Market Outlook
  - 8.3.3.1. Market Size & Forecast
    - 8.3.3.1.1. By Value
  - 8.3.3.2. Market Share & Forecasty
    - 8.3.3.2.1. By Vaccine Type
    - 8.3.3.2.2. By Technology
- 8.3.4. France Veterinary Vaccines Market Outlook
  - 8.3.4.1. Market Size & Forecast
    - 8.3.4.1.1. By Value
  - 8.3.4.2. Market Share & Forecast
    - 8.3.4.2.1. By Vaccine Type
    - 8.3.4.2.2. By Technology
- 8.3.5. Spain Veterinary Vaccines Market Outlook
  - 8.3.5.1. Market Size & Forecast
    - 8.3.5.1.1. By Value
  - 8.3.5.2. Market Share & Forecast
    - 8.3.5.2.1. By Vaccine Type
    - 8.3.5.2.2. By Technology

9. Asia-Pacific Veterinary Vaccines Market Outlook

9.1. Market Size & Forecast
- 9.1.1. By Value
9.2. Market Share & Forecast
- 9.2.1. By Vaccine Type
- 9.2.2. By Technology
- 9.2.3. By Country
9.3. Asia-Pacific: Country Analysis
- 9.3.1. China Veterinary Vaccines Market Outlook
  - 9.3.1.1. Market Size & Forecast
    - 9.3.1.1.1. By Value
  - 9.3.1.2. Market Share & Forecast
    - 9.3.1.2.1. By Vaccine Type
    - 9.3.1.2.2. By Technology
- 9.3.2. India Veterinary Vaccines Market Outlook
  - 9.3.2.1. Market Size & Forecast
    - 9.3.2.1.1. By Value
  - 9.3.2.2. Market Share & Forecast
    - 9.3.2.2.1. By Vaccine Type
    - 9.3.2.2.2. By Technology
- 9.3.3. Japan Veterinary Vaccines Market Outlook
  - 9.3.3.1. Market Size & Forecast
    - 9.3.3.1.1. By Value
  - 9.3.3.2. Market Share & Forecast
    - 9.3.3.2.1. By Vaccine Type
    - 9.3.3.2.2. By Technology
- 9.3.4. South Korea Veterinary Vaccines Market Outlook
  - 9.3.4.1. Market Size & Forecast
    - 9.3.4.1.1. By Value
  - 9.3.4.2. Market Share & Forecast
    - 9.3.4.2.1. By Vaccine Type
    - 9.3.4.2.2. By Technology
- 9.3.5. Australia Veterinary Vaccines Market Outlook
  - 9.3.5.1. Market Size & Forecast
    - 9.3.5.1.1. By Value
  - 9.3.5.2. Market Share & Forecast
    - 9.3.5.2.1. By Vaccine Type
    - 9.3.5.2.2. By Technology

10. South America Veterinary Vaccines Market Outlook

10.1. Market Size & Forecast
- 10.1.1. By Value
10.2. Market Share & Forecast
- 10.2.1. By Vaccine Type
- 10.2.2. By Technology
- 10.2.3. By Country
10.3. South America: Country Analysis
- 10.3.1. Brazil Veterinary Vaccines Market Outlook
  - 10.3.1.1. Market Size & Forecast
    - 10.3.1.1.1. By Value
  - 10.3.1.2. Market Share & Forecast
    - 10.3.1.2.1. By Vaccine Type
    - 10.3.1.2.2. By Technology
- 10.3.2. Argentina Veterinary Vaccines Market Outlook
  - 10.3.2.1. Market Size & Forecast
    - 10.3.2.1.1. By Value
  - 10.3.2.2. Market Share & Forecast
    - 10.3.2.2.1. By Vaccine Type
    - 10.3.2.2.2. By Technology
- 10.3.3. Colombia Veterinary Vaccines Market Outlook
  - 10.3.3.1. Market Size & Forecast
    - 10.3.3.1.1. By Value
  - 10.3.3.2. Market Share & Forecast
    - 10.3.3.2.1. By Vaccine Type
    - 10.3.3.2.2. By Technology

11. Middle East and Africa Veterinary Vaccines Market Outlook

11.1. Market Size & Forecast
- 11.1.1. By Value
11.2. Market Share & Forecast
- 11.2.1. By Vaccine Type
- 11.2.2. By Technology
- 11.2.3. By Country
11.3. MEA: Country Analysis
- 11.3.1. South Africa Veterinary Vaccines Market Outlook
  - 11.3.1.1. Market Size & Forecast
    - 11.3.1.1.1. By Value
  - 11.3.1.2. Market Share & Forecast
    - 11.3.1.2.1. By Vaccine Type
    - 11.3.1.2.2. By Technology
- 11.3.2. Saudi Arabia Veterinary Vaccines Market Outlook
  - 11.3.2.1. Market Size & Forecast
    - 11.3.2.1.1. By Value
  - 11.3.2.2. Market Share & Forecast
    - 11.3.2.2.1. By Vaccine Type
    - 11.3.2.2.2. By Technology
- 11.3.3. UAE Veterinary Vaccines Market Outlook
  - 11.3.3.1. Market Size & Forecast
    - 11.3.3.1.1. By Value
  - 11.3.3.2. Market Share & Forecast
    - 11.3.3.2.1. By Vaccine Type
    - 11.3.3.2.2. By Technology

12. Market Dynamics

12.1. Drivers
12.2. Challenges

13. Market Trends & Developments

13.1. Recent Developments
13.2. Product Launches
13.3. Mergers & Acquisitions

14. Global Veterinary Vaccines Market: SWOT Analysis

15. Competitive Landscape

15.1. Zoetis Inc.
- 15.1.1. Business Overview
- 15.1.2. Technology Offerings
- 15.1.3. Recent Developments
- 15.1.4. Key Personnel
- 15.1.5. SWOT Analysis
15.2. Merck & Co. Inc.
15.3. Virbac
15.4. Hester Biosciences Limited
15.5. Elanco Animal Health
15.6. Boehringer Ingelheim International GmbH
15.7. Ceva Sante Animale
15.8. Phibro Animal Health Corporation
15.9. HIPRA